Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism

  1. Ramos-Cejudo, J.
  2. Oreja-Guevara, C.
  3. Aroeira, L.S.
  4. De Antonio, L.R.
  5. Chamorro, B.
  6. Diez-Tejedor, E.
Aldizkaria:
Journal of Clinical Immunology

ISSN: 0271-9142,  1573-2592

Argitalpen urtea: 2011

Alea: 31

Zenbakia: 4

Orrialdeak: 623-631

Mota: Artikulua

DOI: 10.1007/S10875-011-9522-X GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus